Pharnext also benefits from advice from acknowledged international leaders in the company's scientific and medical fields of interest. 

Professor Bruno Dubois Professor of Neurology at Pierre et Marie Curie University of Paris Director of the INSERM UMR S975 "Cognition Imaging and Brain Diseases" research unit, coordinator of the National Reference Center for "Rare Dementia", coordinator of the National Center for Early-Onset Alzheimer's disease, coordinator of the Ile de France Center for Memory Research and Resources. He also manages the Memory and Alzheimer's Disease Institute at Salpétrière Hospital (Paris).		Professor Jorge Kalil Professor of Medicine and Director of the University of Sao Paulo, Brazil. A former Advisor to the Brazilian Ministry of Health and a founder of the Brazilian Society for Organ Transplantation. He is a Full Member of the Brazilian Academy of Science and received the Medal of Natlonal Scientific Merit in 1998. He chairs the Institute for Investigation in Immunology. He is a Council Member at the International Union of Immunological Societies and chaired the 2007 International Congress of Immunology in Rio de Janeiro.
Professor Eric R. Kandel Columbia University of New York Received the 2000 Nobel Prize in Physiology or Medicine for his work on the molecular basis of short- and long-term memory. A world expert in neurosciences and Professor of Biochemistry and Biophysics at Columbia University, New York.		Professor David Klatzmann Pierre and Marie Curie University of Paris / INSERM / CNRS An international renowned immunologist and an expert in immune system biology and immunotherapy. His skills will enable Pharnext to exploit the potential of PleotherapyTM in the immune system and to expand its pipeline to inflammatory diseases and cancer.
Professor Jean-Marie Lehn Professor at the College de France, Paris. Received the 1987- Nobel Prize in Chemistry and particularly for his synthesis of the cryptands. He was an early innovator in the field of supramolecular chemistry and continues to innovate in this field. He has published over 800 peer-reviewed articles in chemistry journals.		Professor Fabio Macciardi University of Milano, Italy. An internationally acknowledged expert in statistical analysis (particulary multifactorial neuro-genetics and pharmacogenetics).
Professor Klaus Nave Max Planck institute, Göttingen, germany. one of the world's leading experts in neurobiology and the molecular pathology of Charcot-Marie-Tooth disease. Professor of Molecular Biology (Department of Neurogenetics), Director of the Max Planck Institute for Experimental Medicine in Göttingeen (Germany) and Professor of Biology at the University of Heidelberg (germany).		Professor Jean-Marc Orgogozo Professor of Neurology at University of Bordeaux, France. MD, Professor in Neurology, Psychiatry, Neurophysiology and Nuclear Medicine at the Victor Segalen University Victor Segalen of Bordeaux (1965-2001). Head of the Neurology laboratory at pellegrin Hospital in Bordeaux (1993-2006). Head of the Clinical Neuroscience Division (2007-present). Member of international societies and organizations, including the World Federation of Neurology and the World health Organization.
Professor Alan Smith Genzyme (Senior Vice President, Research; Chief Scientific Officer.) Former Vice-President and CSO of Integrated Genetics (acquired by Genzyme in 1989); a former member of the scientific staff at the Imperial Cancer Research Fund (London).		Professor Georges COSTA Rio de Janeiro